Author

Xi Chen

University of OxfordORCID 0009-0002-4302-5710Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Xi Chen12 papers · AstraZeneca (United States)

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Assay:clinical cohort / trial· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

David Andrew CliftoniD· 1 shared Jiandong ZhouiD· 1 shared Lei LüiD· 1 shared Stephen John PayneiD· 1 shared Tamás JózsaiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

David Andrew CliftonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BioengineeringIEEE Journal of Biomedical and Health InformaticsPeer-reviewedFeb 12, 2025

AI-assisted In-silico Trial for the Optimization of Osmotherapy following Ischaemic Stroke

Xi Chen, Lei Lü, Tamás Józsa…·Stephen John Payne

This paper develops an AI-assisted in-silico trial to optimize osmotherapy protocols for ischaemic stroke by predicting intracranial pressure and personalizing treatment based on patient-specific data.

1 citation

humanclinical cohort / trial

𝕏 PostBluesky